Global Stock News

HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering

Article feature image

HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering

MIRAMAR, Fla., July 19, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (NASDAQ:HCWB) (the “Company”), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting…

Click here to view the original article.

Share this article

Scroll to Top